CYP2J2 Gene Polymorphism and Heart Attacks
Author Information
Author(s): Börgel Jan, Bulut Daniel, Hanefeld Christoph, Neubauer Horst, Mügge Andreas, Epplen Jörg T, Holland-Letz Tim, Spiecker Martin
Primary Institution: Ruhr-University, Bochum, Germany
Hypothesis
Does the CYP2J2 G-50T polymorphism influence the risk of myocardial infarction in patients with a high cardiovascular risk profile?
Conclusion
The CYP2J2 G-50T polymorphism did not show a significant role in the development of myocardial infarction, but further research is needed.
Supporting Evidence
- The T-allele was found in 11.1% of patients, with 146 having a history of myocardial infarction.
- Carriers of the T-allele had a higher percentage of myocardial infarctions compared to wild type carriers.
- The odds ratio for myocardial infarction in T-allele carriers was 1.73.
Takeaway
This study looked at a gene that might affect heart attacks in people at risk, but it didn't find strong evidence that it does.
Methodology
Genotyping of the CYP2J2 polymorphism was performed in two patient groups with high cardiovascular risk to assess its correlation with myocardial infarction.
Potential Biases
Potential bias due to reliance on patient recall for myocardial infarction history.
Limitations
The study was retrospective and could not include fatal cardiac events; the sample size may be too small for definitive conclusions.
Participant Demographics
Patients included 512 with obstructive sleep apnea and 488 undergoing coronary angiography, with an average age of 60.1 years.
Statistical Information
P-Value
0.026
Confidence Interval
[1.06–2.83]
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website